We aim to choose the most upstream PI3K as the target, and further validate through cell experiments whether the effective components of Eucommia can activate downstream AKT/mTOR by regulating PI3K, thereby improving MI and HF. The gene discussed is MTOR; the disease is hydrops fetalis.